VERU · Veru Inc.
$2.73
+0.03 (+1.11%)
At close · Aug 14
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These uncertainties raise substantial doubt regarding our ability to continue as a going concern for a period of twelve months subsequent to the issuance date of the financial statements included in this report. Certain elements of our operating plan to alleviate the conditions that raise substantial doubt, including but not limited to our ability to secure equity financing or other financing alternatives, are outside of our control and cannot be included in management's evaluation under the requirements of ASC 205-40, Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern. Accordingly, we have concluded that substantial doubt exists about our ability to continue as a going concern for a period of at least twelve months subsequent to the issuance date of the financial statements included in this report.”View the 10-Q filed Aug 10, 2026
Market Cap
$46.55M
Shares
17.05M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-12 | Canaccord Genuity's 46th Annual Growth Investors Conference | Conference |
| 2026-08-10 | FY 2026 Q3 Earnings Conference Call | Earnings call |
| 2026-07-16 | 2026 Obesity & Weight Loss Drug Development Summit and Pre-Conference Workshop Day | Conference |
| 2026-05-13 | FY 2026 Q2 Earnings Conference Call | Earnings call |
| 2026-03-12 | 2026 Annual Meeting of Shareholders | Shareholder meeting |
| 2026-02-26 | Oppenheimer 36th Annual Healthcare Life Sciences Conference | Conference |
| 2026-02-11 | FY 2026 Q1 Earnings Conference Call | Earnings call |
Source: https://ir.verupharma.com/
Key facts
CIK
863894
CUSIP
92536C202
13F (30d)
61 filings
61 filers
Visit website
Investor relations